Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH)

Parc Sanitari Pere Virgili

Status: Enrolling

Conditions: Poly Pharmacy; Frail Elderly

Treatments: Other: Patient-centered multidisciplinary treatment review

Study type: Interventional

Funder types: Other

Identifiers

NCT07015112

AMIDA-ICH

Details and patient eligibility

About

The goal of this clinical trial is to learn if a multi-professional (conducted by geriatricians, clinical pharmacists, nurses) medication revision, centered on patients' goals and characteristics, can improve treatment adequacy in older adults admitted to an intermediate care hospital.

The main question it aims to answer is: does this approach reduce the average number of medications taken per patient?

Researchers will compare this multi-professional patient-centered revision to the usual standard of care (treatment revision conducted by a clinical pharmacist) to see if the patient-centered revision works in improving treatment adequacy.

Participants admitted to an intermediate care hospital will undergo a comprehensive assessment by a geriatrician, and a medication revision (conducted by a multidisciplinary team or a clinical-pharmacist alone). They will also be asked to fulfill some questionnaires on their health status and attitudes. Any possible adverse events to the medications will be recorded at discharge. Participants will be contacted again three months after discharge to check for any readmission or death.

Enrollment: 300 estimated patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• older adults (65+ years)
• ≥ 3 or more chronic conditions requiring medical therapy
• able to speak Spanish
• capacity to provide informed consent or have a surrogate able to consent on their behalf

Exclusion criteria

• unable to provide informed consent
• anticipated length of hospital stay < 72h
• estimated life expectancy < 3 months
• homeless
• already enrolled in a drug trial

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

300 participants in 2 patient groups

Control (usual care)

No Intervention group

Description:

Control arm will receive usual standard of care

Intervention (patient-centered medication review)

Experimental group

Description:

Intervention arm will receive a multidisciplinary patient-centered medication review

Treatment:

Other: Patient-centered multidisciplinary treatment review